{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:04:29Z","timestamp":1788822269048,"version":"build-2803163510"},"reference-count":57,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurourol. Urodynam."],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1002\/nau.22797","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T18:56:23Z","timestamp":1455389783000},"page":"293-298","source":"Crossref","is-referenced-by-count":25,"title":["Do we understand how botulinum toxin works and have we optimized the way it is administered to the bladder? ICI-RS 2014"],"prefix":"10.1002","volume":"35","author":[{"given":"Apostolos","family":"Apostolidis","sequence":"first","affiliation":[{"name":"2nd Department of Urology; Aristotle University of Thessaloniki; Thessaloniki Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Rahnama'i","sequence":"additional","affiliation":[{"name":"Department of Urology; Maastricht University Medical Centre; Maastricht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Fry","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology; University of Bristol; Bristol United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Dmochowski","sequence":"additional","affiliation":[{"name":"Department of Urological Surgery; Vanderbilt University Medical Center; Nashville Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sahai","sequence":"additional","affiliation":[{"name":"Department of Urology; Guy's Hospital; London United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"10.1002\/nau.22797-BIB0001|nau22797-cit-0001","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1046\/j.1526-4610.43.7s.4.x","article-title":"Synaptic transmission: Inhibition of neurotransmitter release by botulinum toxins","volume":"43","author":"Dolly","year":"2003","journal-title":"Headache"},{"key":"10.1002\/nau.22797-BIB0002|nau22797-cit-0002","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2005.12.010","article-title":"Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity","volume":"49","author":"Apostolidis","year":"2006","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22797-BIB0003|nau22797-cit-0003","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2217\/pmt.14.30","article-title":"Botulinum neurotoxin A for chronic migraine headaches: Does it work and how","volume":"4","author":"Cairns","year":"2014","journal-title":"Pain Manag"},{"key":"10.1002\/nau.22797-BIB0004|nau22797-cit-0004","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.2012.505","article-title":"Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: A meta-analysis","volume":"307","author":"Jackson","year":"2012","journal-title":"Jama"},{"key":"10.1002\/nau.22797-BIB0005|nau22797-cit-0005","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/WNF.0b013e31826538c7","article-title":"Efficacy, tolerability, and immunogenicity of onabotulinumtoxina in a randomized, double-blind, placebo-controlled trial for cervical dystonia","volume":"35","author":"Charles","year":"2012","journal-title":"Clin Neuropharmacol"},{"key":"10.1002\/nau.22797-BIB0006|nau22797-cit-0006","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/nau.22634","article-title":"Chapter 3: Molecular basis for the therapeutic effectiveness of botulinum neurotoxin type A","volume":"33","author":"Dolly","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22797-BIB0007|nau22797-cit-0007","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1002\/nau.22797-BIB0008|nau22797-cit-0008","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.eururo.2009.12.022","article-title":"Distribution of the high-affinity binding site and intracellular target of botulinum toxin type A in the human bladder","volume":"57","author":"Coelho","year":"2010","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22797-BIB0009|nau22797-cit-0009","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.eururo.2012.01.046","article-title":"Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action","volume":"61","author":"Coelho","year":"2012","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22797-BIB0010|nau22797-cit-0010","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/nau.22508","article-title":"Effect of botulinum toxin A on urothelial-release of ATP and expression of SNARE targets within the urothelium","volume":"34","author":"Hanna-Mitchell","year":"2015","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22797-BIB0011|nau22797-cit-0011","first-page":"347","article-title":"Increased levels of SV2A botulinum neurotoxin receptor in clinical sensory disorders and functional effects of botulinum toxins A and E in cultured human sensory neurons","volume":"4","author":"Yiangou","year":"2011","journal-title":"J Pain Res"},{"key":"10.1002\/nau.22797-BIB0012|nau22797-cit-0012","article-title":"Synaptosomal-associated protein 25 (SNAP-25) and Neuropeptide Y in the overactive human bladder and the effect of Botulinum neurotoxin type A (BoNT\/A)","author":"Datta","year":"2012","journal-title":"Eur Urol Suppl"},{"key":"10.1002\/nau.22797-BIB0013|nau22797-cit-0013","doi-asserted-by":"crossref","first-page":"e100336","DOI":"10.1371\/journal.ppat.1003369","article-title":"Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT\/A)","volume":"9","author":"Jacky","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1002\/nau.22797-BIB0014|nau22797-cit-0014","doi-asserted-by":"crossref","first-page":"429213","DOI":"10.1155\/2012\/429213","article-title":"A decade of FGF receptor research in bladder cancer: Past, present, and future challenges","volume":"2012","author":"di Martino","year":"2012","journal-title":"Adv Urol"},{"key":"10.1002\/nau.22797-BIB0015|nau22797-cit-0015","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1073\/pnas.96.6.3200","article-title":"Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals","volume":"96","author":"de Paiva","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/nau.22797-BIB0016|nau22797-cit-0016","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1097\/01.ju.0000049202.56189.54","article-title":"Effect of botulinum toxin A on the autonomic nervous system of the rat lower urinary tract","volume":"169","author":"Smith","year":"2003","journal-title":"J Urol"},{"key":"10.1002\/nau.22797-BIB0017|nau22797-cit-0017","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1464-410X.2009.08619.x","article-title":"Lack of effectiveness of botulinum toxin on isolated detrusor strips and whole bladders from small animals in vitro","volume":"104","author":"Howles","year":"2009","journal-title":"BJU Int"},{"key":"10.1002\/nau.22797-BIB0018|nau22797-cit-0018","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.urology.2012.12.021","article-title":"Botulinum toxin A detrusor injections reduce postsynaptic muscular M2, M3, P2\u00d72, and P2\u00d73 receptors in children and adolescents who have neurogenic detrusor overactivity: A single-blind study","volume":"81","author":"Schulte-Baukloh","year":"2013","journal-title":"Urology"},{"key":"10.1002\/nau.22797-BIB0019|nau22797-cit-0019","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.juro.2010.07.034","article-title":"Immunohistochemical expression of muscarinic receptors in the urothelium and suburothelium of neurogenic and idiopathic overactive human bladders, and changes with botulinum neurotoxin administration","volume":"184","author":"Datta","year":"2010","journal-title":"J Urol"},{"key":"10.1002\/nau.22797-BIB0020|nau22797-cit-0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1254\/jphs.FM0070115","article-title":"Basic and clinical aspects of non-neuronal acetylcholine: Expression of non-neuronal acetylcholine in urothelium and its clinical significance","volume":"106","author":"Yoshida","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1002\/nau.22797-BIB0021|nau22797-cit-0021","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.eururo.2012.03.031","article-title":"Botulinum neurotoxin serotype A suppresses neurotransmitter release from afferent as well as efferent nerves in the urinary bladder","volume":"62","author":"Ikeda","year":"2012","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22797-BIB0022|nau22797-cit-0022","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.neuint.2004.06.001","article-title":"Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury","volume":"45","author":"Khera","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1002\/nau.22797-BIB0023|nau22797-cit-0023","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/01.ju.0000169481.42259.54","article-title":"Decreased sensory receptors P2\u00d73 and Trpv1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity","volume":"174","author":"Apostolidis","year":"2005","journal-title":"J Urol"},{"key":"10.1002\/nau.22797-BIB0024|nau22797-cit-0024","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0022-5347(06)00258-8","article-title":"Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity","volume":"175","author":"Giannantoni","year":"2006","journal-title":"J Urol"},{"key":"10.1002\/nau.22797-BIB0025|nau22797-cit-0025","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of Botulinum toxin type A in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22797-BIB0026|nau22797-cit-0026","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.eururo.2008.04.037","article-title":"Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection","volume":"56","author":"Liu","year":"2009","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22797-BIB0027|nau22797-cit-0027","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.eururo.2010.02.031","article-title":"Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome\/interstitial cystitis","volume":"58","author":"Pinto","year":"2010","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22797-BIB0028|nau22797-cit-0028","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000143189.19835.f3","article-title":"Inhibitory effect of intravesically applied botulinum toxin A in chronic bladder inflammation","volume":"173","author":"Vemulakonda","year":"2005","journal-title":"J Urol"},{"key":"10.1002\/nau.22797-BIB0029|nau22797-cit-0029","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/nau.21068","article-title":"Central inhibitory effect of intravesically applied botulinum toxin A in chronic spinal cord injury","volume":"30","author":"Munoz","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22797-BIB0030|nau22797-cit-0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2478\/v10181-012-0053-z","article-title":"Botulinum toxin type A-induced changes in the chemical coding of dorsal root ganglion neurons supplying the porcine urinary bladder","volume":"15","author":"Bossowska","year":"2012","journal-title":"Pol J Vet Sci"},{"key":"10.1002\/nau.22797-BIB0031|nau22797-cit-0031","doi-asserted-by":"crossref","first-page":"e786","DOI":"10.1016\/S1569-9056(15)60775-8","article-title":"Retrograde transport of botulinum neurotoxin type A (BoNT\/A) to the central nervous system (CNS) and central changes in markers related to lower urinary tract control after bladder injections in rats","volume":"14\/2","author":"Papagiannopoulou","year":"2015","journal-title":"Eur Urol Suppl"},{"key":"10.1002\/nau.22797-BIB0032|nau22797-cit-0032","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00498587","article-title":"125I-labelled botulinum A neurotoxin: Pharmacokinetics in cats after intramuscular injection","volume":"292","author":"Wiegand","year":"1976","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1002\/nau.22797-BIB0033|nau22797-cit-0033","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00500611","article-title":"125I-labeled neurotoxin from Clostridium botulinum A: Preparation, binding to synaptosomes and ascent to the spinal cord","volume":"281","author":"Habermann","year":"1974","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1002\/nau.22797-BIB0034|nau22797-cit-0034","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1464-410X.2007.07137.x","article-title":"Persistence of the synaptosomal-associated protein-25 cleavage product after intradetrusor botulinum toxin A injections in patients with myelomeningocele showing an inadequate response to treatment","volume":"100","author":"Schulte-Baukloh","year":"2007","journal-title":"BJU Int"},{"key":"10.1002\/nau.22797-BIB0035|nau22797-cit-0035","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.juro.2011.10.130","article-title":"Effect of onabotulinumtoxinA on intramural parasympathetic ganglia: An experimental study in the guinea pig bladder","volume":"187","author":"Coelho","year":"2012","journal-title":"J Urol"},{"key":"10.1002\/nau.22797-BIB0036|nau22797-cit-0036","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.eururo.2008.11.009","article-title":"Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment","volume":"55","author":"Roosen","year":"2009","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22797-BIB0037|nau22797-cit-0037","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eururo.2007.12.029","article-title":"Early effect on the overactive bladder symptoms following botulinum neurotoxin type A injections for detrusor overactivity","volume":"54","author":"Kalsi","year":"2008","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22797-BIB0038|nau22797-cit-0038","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0022-5347(06)00590-8","article-title":"Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics","volume":"176","author":"Schmid","year":"2006","journal-title":"J Urol"},{"key":"10.1002\/nau.22797-BIB0039|nau22797-cit-0039","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.eururo.2013.04.001","article-title":"OnabotulinumtoxinA 100U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: A randomised, double-blind, placebo-controlled trial","volume":"64","author":"Chapple","year":"2013","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22797-BIB0040|nau22797-cit-0040","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.juro.2012.12.022","article-title":"OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: Results of a phase 3, randomized, placebo controlled trial","volume":"189","author":"Nitti","year":"2013","journal-title":"J Urol"},{"key":"10.1002\/nau.22797-BIB0041|nau22797-cit-0041","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1002\/nau.22637","article-title":"Chapter 6: Practical aspects of administration of onabotulinumtoxinA","volume":"33","author":"Rovner","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22797-BIB0042|nau22797-cit-0042","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mus.880100514","article-title":"Aminoglycosides and 3,4-diaminopyridine on neuromuscular block caused by botulinum type A toxin","volume":"10","author":"Molgo","year":"1987","journal-title":"Muscle Nerve"},{"key":"10.1002\/nau.22797-BIB0043|nau22797-cit-0043","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00345-008-0362-0","article-title":"A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging","volume":"27","author":"Mehnert","year":"2009","journal-title":"World journal of urology"},{"key":"10.1002\/nau.22797-BIB0044|nau22797-cit-0044","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.sc.3101736","article-title":"Adverse events after botulinum A toxin injection for neurogenic voiding disorders","volume":"43","author":"De Laet","year":"2005","journal-title":"Spinal Cord"},{"key":"10.1002\/nau.22797-BIB0045|nau22797-cit-0045","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00345-011-0736-6","article-title":"Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment","volume":"30","author":"Alloussi","year":"2012","journal-title":"World J Urol"},{"key":"10.1002\/nau.22797-BIB0046|nau22797-cit-0046","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/nau.21054","article-title":"Bladder base\/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics","volume":"30","author":"Kuo","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1002\/nau.22797-BIB0047|nau22797-cit-0047","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1089\/end.2005.19.880","article-title":"Simplified bladder botulinum-toxin delivery technique using flexible cystoscope and 10 sites of injection","volume":"19","author":"Smith","year":"2005","journal-title":"J Endourol"},{"key":"10.1002\/nau.22797-BIB0048|nau22797-cit-0048","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.juro.2010.05.035","article-title":"The effect of botulinum toxin type a on overactive bladder symptoms in patients with multiple sclerosis: A pilot study","volume":"184","author":"Mehnert","year":"2010","journal-title":"J Urol"},{"key":"10.1002\/nau.22797-BIB0049|nau22797-cit-0049","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.eururo.2011.10.043","article-title":"Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity","volume":"61","author":"Manecksha","year":"2012","journal-title":"Eur Urol"},{"key":"10.1002\/nau.22797-BIB0050|nau22797-cit-0050","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.juro.2007.05.136","article-title":"Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity","volume":"178","author":"Kuo","year":"2007","journal-title":"J Urol"},{"key":"10.1002\/nau.22797-BIB0051|nau22797-cit-0051","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/sj.sc.3101593","article-title":"Electromotive drug administration of lidocaine to anesthetize the bladder before botulinum-A toxin injections into the detrusor","volume":"42","author":"Schurch","year":"2004","journal-title":"Spinal Cord"},{"key":"10.1002\/nau.22797-BIB0052|nau22797-cit-0052","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.urology.2010.09.036","article-title":"Intravesical electromotive botulinum toxin type A administration: Part I-Experimental study","volume":"77","author":"Kajbafzadeh","year":"2011","journal-title":"Urology"},{"key":"10.1002\/nau.22797-BIB0053|nau22797-cit-0053","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.urology.2010.06.003","article-title":"Intravesical electromotive botulinum toxin type A administration-part II: Clinical application","volume":"77","author":"Kajbafzadeh","year":"2011","journal-title":"Urology"},{"key":"10.1002\/nau.22797-BIB0054|nau22797-cit-0054","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.juro.2009.03.083","article-title":"Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes","volume":"182","author":"Chuang","year":"2009","journal-title":"J Urol"},{"key":"10.1002\/nau.22797-BIB0055|nau22797-cit-0055","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.juro.2014.07.008","article-title":"Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: A prospective, multicenter, double-blind, randomized trial","volume":"192","author":"Chuang","year":"2014","journal-title":"J Urol"},{"key":"10.1002\/nau.22797-BIB0056|nau22797-cit-0056","doi-asserted-by":"crossref","first-page":"e1091","DOI":"10.1016\/S1569-9056(15)61079-X","article-title":"Relative potency and diffusion capacity of onabotulinumtoxinA and abobotulinumtoxinA after injection in the bladder wall","volume":"14","author":"Oliveira","year":"2015","journal-title":"Eur Urol Suppl"},{"key":"10.1002\/nau.22797-BIB0057|nau22797-cit-0057","doi-asserted-by":"publisher","DOI":"10.1002\/nau.22712","article-title":"Preliminary results of botulinum toxin A switch after first detrusor injection failure as a treatment of neurogenic detrusor overactivity","author":"Peyronnet","year":"2014","journal-title":"Neurourol Urodyn"}],"container-title":["Neurourology and Urodynamics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22797","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fnau.22797","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/nau.22797\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:18:39Z","timestamp":1718360319000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/nau.22797"}},"subtitle":["Do We Understand How Botulinum Toxin Works?"],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.1002\/nau.22797","archive":["Portico"],"relation":{},"ISSN":["0733-2467"],"issn-type":[{"value":"0733-2467","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}